198 related articles for article (PubMed ID: 16214589)
21. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients.
Palmqvist M; Ibsen T; Mellén A; Lötvall J
Am J Respir Crit Care Med; 1999 Jul; 160(1):244-9. PubMed ID: 10390407
[TBL] [Abstract][Full Text] [Related]
22. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
[TBL] [Abstract][Full Text] [Related]
23. Why SMART about second-line treatment when first-line treatment is being ignored?
Currie GP
Chest; 2006 Sep; 130(3):929; author reply 929. PubMed ID: 16963701
[No Abstract] [Full Text] [Related]
24. Salmeterol vs. formoterol: a comparison of rapid bronchodilator effect in a randomized controlled trial.
Singhania N; Dhamija R; Lodha R; Kabra SK
Indian Pediatr; 2008 Mar; 45(3):225-8. PubMed ID: 18367770
[TBL] [Abstract][Full Text] [Related]
25. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
[TBL] [Abstract][Full Text] [Related]
26. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
Lipworth BJ; Jackson C
Am J Respir Crit Care Med; 1999 Dec; 160(6):2125-6. PubMed ID: 10755831
[No Abstract] [Full Text] [Related]
27. Salmeterol versus theophylline in the treatment of asthma.
Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
[TBL] [Abstract][Full Text] [Related]
28. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
Pearlman DS
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
[TBL] [Abstract][Full Text] [Related]
29. Meeting the obligation to balance bioethics and clinical trial design in asthma.
Bleecker ER; Nelson HS; Kraft M; Corren J; Meyers DA; Yancey SW; Anderson WH; Emmett AH; Ortega HA
Am J Respir Crit Care Med; 2010 Apr; 181(7):648-50. PubMed ID: 20335380
[No Abstract] [Full Text] [Related]
30. Salmeterol response and beta(2)-adrenergic receptor genotype.
Jackson C; Lipworth B
J Allergy Clin Immunol; 2007 Jul; 120(1):217-8; author reply 219-20. PubMed ID: 17399780
[No Abstract] [Full Text] [Related]
31. Comments on the Salmeterol Multicenter Asthma Research Trial.
Seymour SM; Sullivan EJ; Chowdhury BA; Meyer RJ; Davi RC
Chest; 2006 Sep; 130(3):930-1; author reply 931. PubMed ID: 16963702
[No Abstract] [Full Text] [Related]
32. Inhaled salmeterol.
Rubin ID
East Afr Med J; 1994 Aug; 71(8):547. PubMed ID: 7867552
[No Abstract] [Full Text] [Related]
33. Long-acting beta-agonists and exercise.
Weinberger M
J Allergy Clin Immunol; 2008 Aug; 122(2):251-3. PubMed ID: 18582922
[No Abstract] [Full Text] [Related]
34. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy.
Weatherall M; Wijesinghe M; Perrin K; Harwood M; Beasley R
Thorax; 2010 Jan; 65(1):39-43. PubMed ID: 20029037
[TBL] [Abstract][Full Text] [Related]
35. Long-acting beta2-agonists in asthma: safety concerns.
Wooltorton E
CMAJ; 2005 Oct; 173(9):1030-1. PubMed ID: 16214904
[No Abstract] [Full Text] [Related]
36. [Comments of the German Airway League and the German Respiratory Society to the US Food and Drug Administration (FDA)'s announcement from February 18th 2010 on the use of long acting beta-2 agonists in treatment of asthma].
Kardos P; Berdel D; Buhl R; Criée CP; Freihorst J; Gillissen A; Karg O; Pfeifer M; Magnussen H; Rabe KF; Teschler H; Vogelmeier C; Welte T; Wettengel R; Worth H
Pneumologie; 2010 Jun; 64(6):333-5. PubMed ID: 20533125
[No Abstract] [Full Text] [Related]
37. beta-adrenergic receptor genotype and response to salmeterol.
Wechsler ME; Israel E
J Allergy Clin Immunol; 2007 Jul; 120(1):218-9; author reply 219-20. PubMed ID: 17399776
[No Abstract] [Full Text] [Related]
38. Loss of bronchoprotection with salmeterol.
D'Urzo AD
Chest; 1996 Jul; 110(1):306. PubMed ID: 8681659
[No Abstract] [Full Text] [Related]
39. Formoterol (Foradil Aerolizer) for asthma.
Med Lett Drugs Ther; 2001 May; 43(1104):39-40. PubMed ID: 11353924
[No Abstract] [Full Text] [Related]
40. Profiles of measured and perceived bronchodilation. A placebo-controlled cross-over trial comparing formoterol and salmeterol in moderate persistent asthma.
Schermer TR; Hoff WJ; Greefhorst AP; Creemers JP; Sips AP; Westbroek J; van Herwaarden CL
Pulm Pharmacol Ther; 2004; 17(4):205-12. PubMed ID: 15219265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
